Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine vs Conventional Chemotherapy Maintenance in t(8;21) AML
NCT03026842Phase 4Unknown
- Sponsor
- The First Hospital of Jilin University
- Start
- Jan 2017
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of decitabine in acute myeloid leukemia (AML), sponsored by The First Hospital of Jilin University. Status: unknown.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT03026842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03026842.